⌘K

Login Start Free

Home/Filings/4/0001193125-25-307211

4//SEC Filing

MORTIMER IAN 4

Accession 0001193125-25-307211

CIK 0001582313other

View on SEC.gov Company Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 8:20 PM ET

Size

5.4 KB

Accession

0001193125-25-307211

Insider Transaction Report

Form 4

Period: 2025-11-28

Xenon Pharmaceuticals Inc.XENE

DirectorPRESIDENT & CEO

Transactions

Sale
Common Shares
2025-11-28$45.01/sh−97$4,366→ 31,205 total

Holdings

Common Shares
(indirect: By Spouse)
14,300

Footnotes (1)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeother

Related Parties

1

filerCIK 0001619961

Filing Metadata

Form type: 4
Filed: Dec 2, 7:00 PM ET
Accepted: Dec 3, 8:20 PM ET
Size: 5.4 KB

View on SEC.gov